Proteomic analysis of the effects of caffeine in a neonatal rat model of hypoxic‐ischemic white matter damage

Abstract

Caffeine may have clinical applications in the management of prophylactic hypoxic-ischemic WMD; its effects may be mediated by proteins related to myelin development and synapse formation through SIRT2.